Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 14 of 123)
- Relevance
  Sort by

Glioblastoma Multiforme Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4348EUR$4,750USD£3,695GBP

Febrile Neutropenia - Pipeline Insight, 2025

 Clinical Trials
April 2025
65 Pages
Global

From

€1373EUR$1,500USD£1,167GBP

Thyroid Cancer Drugs Market by Drug Type, Mode of Administration, Stage of Disease, Cancer Type, End User - Global Forecast 2025-2030

 Report
October 2024
199 Pages
Global

From

€3245EUR$3,545USD£2,758GBP

€3606EUR$3,939USD£3,064GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2289EUR$2,500USD£1,945GBP

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
746 Pages
Global

From

€2289EUR$2,500USD£1,945GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
69 Pages
Global

From

€3204EUR$3,500USD£2,723GBP

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
871 Pages
Global

From

€2289EUR$2,500USD£1,945GBP

Liposome Development and Liposome Manufacturing Services Market, 2022-2035: Distribution by Type of Product Formulation, Scale of Operation, End User Industry, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
December 2022
226 Pages
Global

From

€4393EUR$4,799USD£3,734GBP

Neuroblastoma Drugs Market By Type, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
January 2024
256 Pages
Global

From

€2288EUR$2,499USD£1,944GBP

€3268EUR$3,570USD£2,777GBP

Brain Metastasis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1831EUR$2,000USD£1,556GBP

Glioblastoma Multiforme Treatment Market Report by Drug Type, Route of Administration, Type of Molecule, Distribution Channel, and Region 2024-2032

 Report
April 2024
138 Pages
Global

From

€2745EUR$2,999USD£2,333GBP

Glioma - Pipeline Insight, 2025

 Clinical Trials
April 2025
450 Pages
Global

From

€4577EUR$5,000USD£3,890GBP

Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027

 Report
January 2023
189 Pages
Global

From

€3845EUR$4,200USD£3,268GBP

Global Cancer Vaccine Market & Clinical Trials Outlook 2028

 Report
July 2022
600 Pages
Global

From

€3021EUR$3,300USD£2,567GBP

Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
178 Pages
Global

From

€4119EUR$4,500USD£3,501GBP

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1831EUR$2,000USD£1,556GBP

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025

 Report
April 2025
250 Pages
Global

From

€3657EUR$3,995USD£3,108GBP

Merkel Cell Carcinoma Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Antibacterial Drugs Market 2024-2028

 Report
July 2024
189 Pages
Global

From

€2289EUR$2,500USD£1,945GBP

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034

 Report
October 2023
428 Pages
Global

From

€5297EUR$5,990USD£4,350GBP

2,452 Results (Page 14 of 123)
- 1
- 12
- 13
- 14
- 15
- 16

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.